Surgical outcomes of membrane-tube-type glaucoma shunt device in indigenous West Africans
| Autor: | Olusola Olawoye, Adeyinka O. Ashaye, Young Hoon Hwang, Jong Chul Han, Tarela F. Sarimiye, Byung Heon Ahn |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Intraocular pressure
medicine.medical_specialty genetic structures 030231 tropical medicine Glaucoma glaucoma shunt device 03 medical and health sciences 0302 clinical medicine Refractory Ophthalmology West Africa Occlusion Medicine Original Research Glaucoma shunt device Minimal risk business.industry Clinical Ophthalmology medicine.disease eye diseases Surgery West african glaucoma Standard error 030221 ophthalmology & optometry sense organs business intraocular pressure |
| Zdroj: | Clinical Ophthalmology (Auckland, N.Z.) |
| ISSN: | 1177-5483 |
| Popis: | Olusola Olawoye,1,2 Tarela Sarimiye,1,2 Adeyinka Ashaye,1,2 Young Hoon Hwang,3 Jong Chul Han,4 Byung Heon Ahn3 1Department of Ophthalmology, College of Medicine, University of Ibadan, 2Department of Ophthalmology, University College Hospital, Ibadan, Nigeria; 3Department of Ophthalmology, Konyang University, Kim’s Eye Hospital, Myung-Gok Eye Research Institute, 4Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, South Korea Purpose: The aim of this study was to report the safety and efficacy of the membrane-tube (MT)-type glaucoma shunt device (Finetube MT) in the management of refractory glaucoma in indigenous West Africans.Methods: The Finetube MT was implanted into 25 eyes of 25 West African patients with refractory glaucoma. These patients had inadequate intraocular pressure (IOP) control despite maximum tolerable IOP-lowering medications with or without previous ocular surgeries. IOP, postoperative complications, interventions, visual acuities, and the number of IOP-lowering medications were analyzed preoperatively and postoperatively.Results: The mean (standard deviation [SD]) age of the patients was 49.7 (20.9)years. The mean (SD) follow-up duration was 21.0 (10.6)months. Postoperatively, the mean (SD) IOP reduced from a preoperative value of 38.1 (10.3)mmHg to 14.5 (4.6), 16.1 (7.8), and 14.7 (3.0)mmHg at 1, 2, and 3years postoperatively, respectively, representing 61.9%, 57.7%, and 61.4% reduction from baseline (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|